S21-197 Correction of polycythemia vera via CRISPR/AAV6 genome editing Polycythemia vera is a rare blood cancer characterized by the hyperproliferation of red blood cells, leading to coagulation events like strokes and heart attacks. Matthew Porteus Michael Cromer